-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Silexion Therapeutics Corp quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2023 to 31 Dec 2025.
- Silexion Therapeutics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Dec 2025 was $221,000.
- Silexion Therapeutics Corp Net Cash Provided by (Used in) Financing Activities for the twelve months ending 31 Dec 2025 was $15,640,000.
- Silexion Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $15,640,000, a 206% increase from 2024.
- Silexion Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $5,104,000, a 878% increase from 2023.